Federation des caisses Desjardins du Quebec
Position in NBIX — Neurocrine Biosciences Inc
CIK 2022297
LEVIS, A8
Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,128,218
-$13,637,276 QoQ
Shares Held
8,564
-91.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $37,941,198 across 32 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
105,890 | $12,517,254 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
285,623 | $8,602,962 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
11,255 | $6,673,988 | |
| 4 | ALKS |
Alkermes plc.
|
66,144 | $2,338,851 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
26,930 | $2,070,915 | |
| 6 | VTRS |
Viatris Inc
|
94,833 | $1,281,191 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
51,137 | $1,223,707 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
8,564 | $1,128,218 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,128,218 | 8,564 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,765,494 | 104,107 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $14,525,678 | 103,474 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,219,308 | 113,130 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,791,995 | 115,660 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,358,295 | 127,167 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,073,534 | 139,503 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $15,107,216 | 109,735 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,635,161 | 113,364 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $22,632,151 | 171,768 | Shares | Defined | 2024-08-15 | |
| 2023-09-30 | $19,846,462 | 176,413 | Shares | Defined | 2024-08-15 | |
| 2023-06-30 | $16,447,333 | 174,415 | Shares | Defined | 2024-08-15 | |
| 2023-03-31 | $962,602 | 9,510 | Shares | Defined | 2024-08-15 | |
| 2022-12-31 | $155,630 | 1,303 | Shares | Defined | 2024-08-15 | |
| 2022-09-30 | $103,023 | 970 | Shares | Defined | 2024-08-15 | |
| 2022-06-30 | $94,555 | 970 | Shares | Defined | 2024-08-15 | |
| 2021-03-31 | $40,358 | 415 | Shares | Defined | 2024-08-30 | |
| 2020-12-31 | $39,777 | 415 | Shares | Defined | 2024-08-30 | |
| 2020-09-30 | $288 | 3 | Shares | Defined | 2024-08-30 | |
| 2020-03-31 | $692 | 8 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||